Cambrian Bio's Series Investor
The company develops therapies and medicines to create interventions that treat specific diseases first, then deploy them as preventative medicines to improve quality of life, enabling scientists to transmit their discoveries from the lab into the clinic and bring medicines to patients in Bio 2025 : Valuation, Funding & ?
